107 related articles for article (PubMed ID: 11533907)
21. The social costs of alcohol misuse in Estonia.
Saar I
Eur Addict Res; 2009; 15(1):56-62. PubMed ID: 19052463
[TBL] [Abstract][Full Text] [Related]
22. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
23. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
24. Conceptual framework for estimating the social cost of drug abuse.
French MT; Rachal JV; Hubbard RL
J Health Soc Policy; 1991; 2(3):1-22. PubMed ID: 10170913
[TBL] [Abstract][Full Text] [Related]
25. The economic burden of informal care.
Andersson A; Levin LA; Emtinger BG
Int J Technol Assess Health Care; 2002; 18(1):46-54. PubMed ID: 11987441
[TBL] [Abstract][Full Text] [Related]
26. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
27. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
28. Workers' drinking patterns: the impact on absenteeism in the Australian work-place.
Roche AM; Pidd K; Berry JG; Harrison JE
Addiction; 2008 May; 103(5):738-48. PubMed ID: 18412752
[TBL] [Abstract][Full Text] [Related]
29. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
30. Direct and indirect cost of general aviation crashes.
Scuffham P; Chalmers D; O'Hare D; Wilson E
Aviat Space Environ Med; 2002 Sep; 73(9):851-8. PubMed ID: 12234034
[TBL] [Abstract][Full Text] [Related]
31. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
32. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.
Kobelt G; Lindgren P; Lindroth Y; Jacobson L; Eberhardt K
Rheumatology (Oxford); 2005 Sep; 44(9):1169-75. PubMed ID: 15956093
[TBL] [Abstract][Full Text] [Related]
33. Labor Supply of Poor Residents in Metropolitan Miami, Florida: The Role of Depression and the Co-Morbid Effects of Substance Use.
Alexandre PK; French MT
J Ment Health Policy Econ; 2001 Dec; 4(4):161-173. PubMed ID: 12119426
[TBL] [Abstract][Full Text] [Related]
34. Estimated cost of alcohol to the New Zealand public hospital system.
Ashton T; Casswell S
N Z Med J; 1984 Oct; 97(765):683-6. PubMed ID: 6592482
[TBL] [Abstract][Full Text] [Related]
35. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
[TBL] [Abstract][Full Text] [Related]
36. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
Chang S; Long SR; Kutikova L; Bowman L; Finley D; Crown WH; Bennett CL
J Clin Oncol; 2004 Sep; 22(17):3524-30. PubMed ID: 15337801
[TBL] [Abstract][Full Text] [Related]
37. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
[TBL] [Abstract][Full Text] [Related]
38. [Economic burden of cancer in South Korea for the year 2005].
Kim J; Hahm MI; Park EC; Park JH; Park JH; Kim SE; Kim SG
J Prev Med Public Health; 2009 May; 42(3):190-8. PubMed ID: 19491563
[TBL] [Abstract][Full Text] [Related]
39. Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes.
Jacob-Tacken KH; Koopmanschap MA; Meerding WJ; Severens JL
Health Econ; 2005 May; 14(5):435-43. PubMed ID: 15497201
[TBL] [Abstract][Full Text] [Related]
40. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
Bolin K; Mörk AC; Willers S; Lindgren B
Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
